Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | INVICTA Invicta Diagnostic Ltd. Pharma · SME | METROPOLIS Metropolis Healthcare Limited Pharma · Micro | VIYASH Viyash Scientific Limited Pharma · Micro | THYROCARE Thyrocare Technologies Limited Pharma · Micro |
|---|---|---|---|---|
| Final Score | 63 | 38 | 46 | 52 |
| Verdict | UNDERVALUED | WATCHLIST | FAIR VALUE | FAIR VALUE |
| Style | Growth at Value | WATCHLIST | Financial Turnaround | Premium Compounder |
| Piotroski | 8/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 20/30 | 0/30 | 2/30 | 0/30 |
| Growth | 20/25 | 8/25 | 14/25 | 12/25 |
| Quality | 11/20 | 9/20 | 5/20 | 20/20 |
| Balance Sheet | 13/15 | 9/15 | 12/15 | 8/15 |
| Cash Flow | 1/10 | 7/10 | 8/10 | 8/10 |
| Price | ₹61.2 | ₹534 | ₹260 | ₹549 |
| P/E | 13.90 | 56.50 | 56.30 | 54.20 |
| P/B | 1.57 | 7.34 | 3.86 | 14.89 |
| ROE | 17.30% | 13.80% | 11.00% | 28.40% |
| ROCE | 22.80% | 17.80% | 19.00% | 35.40% |
| Debt / Equity | 0.00 | 0.15 | 0.17 | 0.09 |
| FCF Yield | — | 1.15% | 2.13% | 2.18% |
| Dividend Y | — | 0.37% | — | 1.70% |
| Altman Z | 8.16 | 8.61 | 6.22 | 9.35 |
| Promoter % | 66.70% | 48.86% | 61.31% | 60.92% |
| Mkt Cap (₹Cr) | 76.90 | 11092.00 | 11247.00 | 8718.00 |
| Graham # | ₹62.14 | ₹122.73 | ₹78 | ₹92.08 |
| Fair PE | 42.0 | 8.7 | 42.0 | 23.5 |
| MoS % | +66.9% | -568.5% | -52.5% | -128.3% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startINVICTA71
METROPOLIS25
VIYASH124
THYROCARE56